3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Craniopharyngioma
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Recurrent Head and Neck Carcinoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Meningioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Interventions
Temozolomide
40
Magnetic Resonance Spectroscopy
19
Radiotherapy
18
Specimen Handling
14
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
poly ICLC
2
olaparib
2
lutetium Lu 177 dotatate
2
durvalumab
2
dabrafenib
2
contrast agent BR1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Proton Therapy
×
90 days
×
Clear all
No trials found.